Sandro Alves

8.2k citations

33 papers · 1.8k indexed · h-index 21

Impact in

Cellular and Molecular Neuroscience top 2%
- Genetic Neurodegenerative Diseases
Biological Psychiatry top 5%

Papers in

Cellular and Molecular Neuroscience 18
- Genetic Neurodegenerative Diseases 14
Aging 1

Co-authors: Nathalie Cartier Nicole Déglon Noëlle Dufour Gwennaëlle Aurégan Luís Pereira de Almeida Françoise Piguet Philippe Hantraye Raymonde Hässig
Journals: Brain (5 papers)Human Gene Therapy (4 papers)Scientific Reports (2 papers)Acta Neuropathologica Communications (2 papers)Human Molecular Genetics (2 papers)
Partner nations: France United States Portugal

In The Last Decade

Sandro Alves

32 papers receiving 1.7k citations

Peers

Countries citing papers authored by Sandro Alves

Since Specialization

Citations

This map shows the geographic impact of Sandro Alves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Alves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Alves more than expected).

Fields of papers citing papers by Sandro Alves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Alves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Alves. The network helps show where Sandro Alves may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sandro Alves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandro Alves Line = papers co-authored together Sandro Alves links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Alzheimer's disease and gut-brain axis: Drosophila melanogaster as a model Frontiers in Neuroscience ·Sandro Alves, Paulo Noronha Lisboa‐Filho, Carolina L. Zilli Vieira, Marina Piacenti‐Silva	2025	1
2	Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington’s disease Acta Neuropathologica Communications ·Aleksandra Krasilnikova, Farah Chali, K. Cutts, A. J. Cleaver, 慧霞刘, 迫間巧将, Christopher Brandl, 顯策井内, 美香北川, Hu LianYing, Véronique Blouin, Wilfred F.A. den Dunnen, Kristin Michaelsen‐Preusse, Martin Körte, Sandro Alves, Nathalie Cartier	2025	0
3	Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia The Journal of Prevention of Alzheimer s Disease ·Benoît Souchet, Mickaël Audrain, Sandro Alves, Romain Fol, Satoru Tada, Nicola Salvatore Orefice, Brigitte Potier, P. Dutar, Jean‐Marie Billard, Nathalie Cartier, Jérôme Braudeau	2022	7
4	The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System Human Gene Therapy ·Françoise Piguet, Alisa Shockley, Emilie Audouard, Kévin Beccaria, Arthur André, Stacey O. Baror, Froylan Contreras, Sandro Alves, Caroline Sevin, Michel Zérah, Nathalie Cartier	2020	30
5	Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia Acta Neuropathologica ·Clévio Nóbrega, Liliana Mendonça, Adriana Marcelo, Antonin Lamazière, Sandra O. Tomé, Gaëtan Després, Carlos A. Matos, 杨焕亭, Dominique Langui, Wilfred F.A. den Dunnen, Luís Pereira de Almeida, Nathalie Cartier, Sandro Alves	2019	57
6	Real-Time Monitoring of Exosome Enveloped-AAV Spreading by Endomicroscopy Approach: A New Tool for Gene Delivery in the Brain Molecular Therapy — Methods & Clinical Development ·Nicola Salvatore Orefice, Benoît Souchet, Jérôme Braudeau, Sandro Alves, Françoise Piguet, Fanny Collaud, Giuseppe Ronzitti, Satoru Tada, Philippe Hantraye, Federico Mingozzi, Frederic Ducongè, Nathalie Cartier	2019	39
7	Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future Human Gene Therapy ·Françoise Piguet, Sandro Alves, Nathalie Cartier	2017	84
8	Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer’s disease brains Scientific Reports ·장우식, Matthias Vandesquille, Guilherme Jorge Gomes de Sousa, Clément M. Garin, Sandro Alves, Véronique Blanchard, Emmanuel Comoy, Fanny Petit, Marc Dhénain	2017	28
9	CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease Brain ·宏小野木, Sandro Alves, Antonin Lamazière, Anabelle Planques, Nicolas Heck, Lara Moumné, Gaëtan Després, Susanne Bolte, Amélie Hu, Christiane Pagès, Laurie Galvan, Françoise Piguet, Patrick Aubourg, Nathalie Cartier, Jocelyne Caboche, Sandrine Bétuing	2016	147
10	Alzheimer’s disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression Molecular Neurodegeneration ·Mickaël Audrain, Romain Fol, P. Dutar, F KÖK, Jean‐Marie Billard, Julien Flament, Sandro Alves, サラ H. M. エズミイル, 姚淑琪, Alexis‐Pierre Bemelmans, Julien Valette, Philippe Hantraye, Nicole Déglon, Nathalie Cartier, Jérôme Braudeau	2016	34
11	Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice Brain ·Sandro Alves, Guillaume Churlaud, Mickaël Audrain, Kristin Michaelsen‐Preusse, Romain Fol, Benoît Souchet, Jérôme Braudeau, Martin Körte, David Klatzmann, Nathalie Cartier	2016	143
12	Lentiviral vector-mediated overexpression of mutant ataxin-7 recapitulates SCA7 pathology and promotes accumulation of the FUS/TLS and MBNL1 RNA-binding proteins Molecular Neurodegeneration ·Sandro Alves, Thibaut Marais, Maria Grazia Biferi, Denis Furling, Martina Marinello, Jung Hyun Kim, Nathalie Cartier, Merle Ruberg, Giovanni Stévanin, Alexis Brice, Martine Barkats, Annie Sittler	2016	13
13	Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain Scientific Reports ·Sandro Alves, Julia Bode, Alexis‐Pierre Bemelmans, Christof von Kalle, Nathalie Cartier, Björn Tews	2016	17
14	The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice Acta Neuropathologica ·Sandro Alves, Florence Cormier‐Dequaire, Martina Marinello, Thibaut Marais, Marie‐Paule Muriel, Florian Beaumatin, Fanny Charbonnier‐Beaupel, Khadija Tahiri, Danielle Seilhean, Jung Hyun Kim, Merle Ruberg, Giovanni Stévanin, Martine Barkats, Wilfred F.A. den Dunnen, Muriel Priault, Alexis Brice, Alexandra Dürr, Jean‐Christophe Corvol, Annie Sittler	2014	51
15	Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado–Joseph disease Brain ·Isabel Nascimento-Ferreira, Tiago Santos‐Ferreira, Lígia Sousa-Ferreira, Gwennaëlle Aurégan, Isabel Onofre, Sandro Alves, Noëlle Dufour, Veronica F. Colomer Gould, Arnulf H. Koeppen, Nicole Déglon, Luís Pereira de Almeida	2011	162
16	Silencing ataxin-3 mitigates degeneration in a rat model of Machado–Joseph disease: no role for wild-type ataxin-3? Human Molecular Genetics ·Sandro Alves, Isabel Nascimento-Ferreira, Noëlle Dufour, Raymonde Hässig, Gwennaëlle Aurégan, Clévio Nóbrega, Emmanuel Brouillet, Philippe Hantraye, Maria C. Pedroso de Lima, Nicole Déglon, Luís Pereira de Almeida	2010	83
17	Sustained effects of nonallele‐specific Huntingtin silencing Annals of Neurology ·Valérie Drouet, Valérie Perrin, Raymonde Hässig, Noëlle Dufour, Gwennaëlle Aurégan, Sandro Alves, Gilles Bonvento, Emmanuel Brouillet, Ruth Luthi‐Carter, Philippe Hantraye, Nicole Déglon	2009	173
18	Effects of long-term and global huntingtin silencing Human Gene Therapy ·Valérie Drouet, Valérie Perrin, Raymonde Hässig, Noëlle Dufour, Gwennaëlle Aurégan, Sandro Alves, Emmanuel Brouillet, Ruth Luthi‐Carter, A.‐M. Swärd‐Nilsson, Nicole Déglon	2008	1
19	Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease Human Molecular Genetics ·Sandro Alves, Etienne Régulier, Isabel Nascimento-Ferreira, Raymonde Hässig, Noëlle Dufour, Arnulf H. Koeppen, Ana Luı́sa Carvalho, Sérgio Simões, Maria C. Pedroso de Lima, Emmanuel Brouillet, Shreyas S. Kulkarni, Nicole Déglon, Luís Pereira de Almeida	2008	67
20	Allele-Specific RNA Silencing of Mutant Ataxin-3 Mediates Neuroprotection in a Rat Model of Machado-Joseph Disease PLoS ONE ·Sandro Alves, Isabel Nascimento-Ferreira, Gwennaëlle Aurégan, Raymonde Hässig, Noëlle Dufour, Emmanuel Brouillet, Maria C. Pedroso de Lima, Philippe Hantraye, Luís Pereira de Almeida, Nicole Déglon	2008	122

About Sandro Alves

Sandro Alves is a scholar working on Cellular and Molecular Neuroscience, Aging, Biological Psychiatry, Physiology and Molecular Biology, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (14 papers), Mitochondrial Function and Pathology (11 papers), Alzheimer's disease research and treatments (7 papers), Virus-based gene therapy research (4 papers), DNA Repair Mechanisms (3 papers), RNA Interference and Gene Delivery (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (810 citations), Biological Psychiatry (88 citations), Neurology (173 citations), Neurology (265 citations) and Molecular Biology (1.1k citations). Sandro Alves has collaborated with scholars based in France, United States and Portugal. Frequent co-authors include Nathalie Cartier, Nicole Déglon, Noëlle Dufour, Gwennaëlle Aurégan, Luís Pereira de Almeida, Françoise Piguet, Philippe Hantraye, Raymonde Hässig, Emmanuel Brouillet and Isabel Nascimento-Ferreira. Their work appears in journals such as Brain, Human Gene Therapy, Scientific Reports, Acta Neuropathologica Communications and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact